لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Morschhauser F; Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France., Bouabdallah K; Hopital Haut-Levêque, Centre Hospitalier Regional Universitaire de Bordeaux, Pessac, France., Stilgenbauer S; Internal Medicine III, Ulm University, Ulm, Germany., Thieblemont C; Hemato-Oncology Department, Hôpital Saint-Louis and Diderot University, Paris, France., de Guibert S; Hôpital de Pontchaillou, Rennes, France., Zettl F; Universitätsmedizin Göttingen, Göttingen, Germany., Gelbert LM; LMG PharmaTech, LLC., Indianapolis, Indiana, USA., Turner KP; Eli Lilly and Company, Indianapolis, Indiana, USA., Prasad Kambhampati SR; Eli Lilly and Company, Indianapolis, Indiana, USA., Li L; Eli Lilly and Company, Indianapolis, Indiana, USA., Li LQ; Eli Lilly and Company, Indianapolis, Indiana, USA., Buchanan S; Eli Lilly and Company, Indianapolis, Indiana, USA., Barriga S; Eli Lilly and Company, Indianapolis, Indiana, USA., Bear MM; Eli Lilly and Company, Indianapolis, Indiana, USA., Wilhelm M; Klinikum Nürnberg Nord, Nürnberg, Germany., Hess G; Universitätsmedizin Mainz, Mainz, Germany.

المصدر: Haematologica [Haematologica] 2021 Mar 01; Vol. 106 (3), pp. 859-862. Date of Electronic Publication: 2021 Mar 01.

نوع المنشور: Clinical Trial, Phase II; Letter

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Mantle-Cell*/drug therapy, Adult ; Aminopyridines/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzimidazoles/adverse effects ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Recurrence ; Treatment Outcome

المؤلفون: Wang H; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Cai S; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Anhui Provincial Cancer Hospital, Hefei, Anhui, China; and., Bailey BJ; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Reza Saadatzadeh M; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Goodman Campbell Brain and Spine, Department of Neurosurgery., Ding J; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Goodman Campbell Brain and Spine, Department of Neurosurgery., Tonsing-Carter E; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Indiana University Simon Cancer Center.; Department of Pharmacology and Toxicology., Georgiadis TM; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Zachary Gunter T; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Long EC; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Minto RE; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Gordon KR; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Sen SE; Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis., Cai W; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Eitel JA; Department of Radiology and Imaging Science, Indiana University, Indianapolis, Indiana., Waning DL; Indiana University Simon Cancer Center.; Department of Medicine, Division of Endocrinology., Bringman LR; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine., Wells CD; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine., Murray ME; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Sarkaria JN; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Gelbert LM; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Jones DR; Division of Clinical Pharmacology., Cohen-Gadol AA; Indiana University Simon Cancer Center.; Goodman Campbell Brain and Spine, Department of Neurosurgery., Mayo LD; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Indiana University Simon Cancer Center., Shannon HE; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health., Pollok KE; Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Section of Pediatric Hematology/Oncology, Riley Hospital for Children at Indiana University Health.; Indiana University Simon Cancer Center.; Department of Pharmacology and Toxicology.

المصدر: Journal of neurosurgery [J Neurosurg] 2017 Feb; Vol. 126 (2), pp. 446-459. Date of Electronic Publication: 2016 May 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Neurological Surgeons Country of Publication: United States NLM ID: 0253357 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1933-0693 (Electronic) Linking ISSN: 00223085 NLM ISO Abbreviation: J Neurosurg Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Alkylating/*therapeutic use , Brain Neoplasms/*therapy , Glioblastoma/*therapy , Imidazoles/*therapeutic use , Piperazines/*therapeutic use , Proto-Oncogene Proteins c-mdm2/*antagonists & inhibitors , Temozolomide/*therapeutic use, Animals ; Brain Neoplasms/pathology ; Combined Modality Therapy ; Disease Models, Animal ; Glioblastoma/pathology ; Humans ; Xenograft Model Antitumor Assays

المؤلفون: Sánchez-Martínez C; Discovery Chemistry Research and Technologies, Eli Lilly and Company, Alcobendas (Madrid) 28108, Spain. Electronic address: sanchez-martinez_concepcion@lilly.com., Gelbert LM; Herman B Wells Center for Pediatric Research, Section of Pediatric Hematology, Oncology, Indiana University, Indianapolis, IN 46202, United States., Lallena MJ; Discovery Chemistry Research and Technologies, Eli Lilly and Company, Alcobendas (Madrid) 28108, Spain., de Dios A; Discovery Chemistry Research and Technologies, Eli Lilly and Company, Indianapolis, IN 46285, United States.

المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 Sep 01; Vol. 25 (17), pp. 3420-35. Date of Electronic Publication: 2015 Jun 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Cyclin-Dependent Kinase Inhibitor Proteins/*metabolism , Neoplasms/*drug therapy, Antineoplastic Agents/pharmacology ; Cell Cycle ; Humans